BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8489524)

  • 1. Vav: a potential link between tyrosine kinases and ras-like GTPases in hematopoietic cell signaling.
    Hu P; Margolis B; Schlessinger J
    Bioessays; 1993 Mar; 15(3):179-83. PubMed ID: 8489524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vav: function and regulation in hematopoietic cell signaling.
    Bonnefoy-BĂ©rard N; Munshi A; Yron I; Wu S; Collins TL; Deckert M; Shalom-Barak T; Giampa L; Herbert E; Hernandez J; Meller N; Couture C; Altman A
    Stem Cells; 1996 May; 14(3):250-68. PubMed ID: 8724692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rac-1 dependent stimulation of the JNK/SAPK signaling pathway by Vav.
    Crespo P; Bustelo XR; Aaronson DS; Coso OA; Lopez-Barahona M; Barbacid M; Gutkind JS
    Oncogene; 1996 Aug; 13(3):455-60. PubMed ID: 8760286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vav cooperates with Ras to transform rodent fibroblasts but is not a Ras GDP/GTP exchange factor.
    Bustelo XR; Suen KL; Leftheris K; Meyers CA; Barbacid M
    Oncogene; 1994 Aug; 9(8):2405-13. PubMed ID: 8036025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor-1 induces rapid tyrosine phosphorylation of the vav proto-oncogene product.
    Uddin S; Yetter A; Katzav S; Hofmann C; White MF; Platanias LC
    Exp Hematol; 1996 Apr; 24(5):622-7. PubMed ID: 8605967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vav transformation requires activation of multiple GTPases and regulation of gene expression.
    Palmby TR; Abe K; Karnoub AE; Der CJ
    Mol Cancer Res; 2004 Dec; 2(12):702-11. PubMed ID: 15634759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hematopoietically expressed vav proto-oncogene shares homology with the dbl GDP-GTP exchange factor, the bcr gene and a yeast gene (CDC24) involved in cytoskeletal organization.
    Adams JM; Houston H; Allen J; Lints T; Harvey R
    Oncogene; 1992 Apr; 7(4):611-8. PubMed ID: 1565462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single point mutations in the SH2 domain impair the transforming potential of vav and fail to activate proto-vav.
    Katzav S
    Oncogene; 1993 Jul; 8(7):1757-63. PubMed ID: 8510922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyrosine phosphorylation and activation of Vav GTP/GDP exchange activity in antigen receptor-triggered B cells.
    Gulbins E; Langlet C; Baier G; Bonnefoy-Berard N; Herbert E; Altman A; Coggeshall KM
    J Immunol; 1994 Mar; 152(5):2123-9. PubMed ID: 8133029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vav: Captain Hook for signal transduction?
    Katzav S
    Crit Rev Oncog; 1995; 6(2):87-97. PubMed ID: 8792085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 3 and erythropoietin induce association of Vav with Tec kinase through Tec homology domain.
    Machide M; Mano H; Todokoro K
    Oncogene; 1995 Aug; 11(4):619-25. PubMed ID: 7651724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular analysis of Ras activation by tyrosine phosphorylated Vav.
    Gulbins E; Schlottmann K; Brenner B; Lang F; Coggeshall KM
    Biochem Biophys Res Commun; 1995 Dec; 217(3):876-85. PubMed ID: 8554611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product.
    Crespo P; Schuebel KE; Ostrom AA; Gutkind JS; Bustelo XR
    Nature; 1997 Jan; 385(6612):169-72. PubMed ID: 8990121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proto-oncogene products Vav and c-Cbl are involved in the signal transduction through Grb2/Ash in hematopoietic cells.
    Hanazono Y; Odai H; Sasaki K; Iwamatsu A; Yazaki Y; Hirai H
    Acta Haematol; 1996; 95(3-4):236-42. PubMed ID: 8677749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutagenic analysis of Vav reveals that an intact SH3 domain is required for transformation.
    Groysman M; Nagano M; Shaanan B; Katzav S
    Oncogene; 1998 Sep; 17(12):1597-606. PubMed ID: 9794237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vav and Ras induce fibroblast transformation by overlapping signaling pathways which require c-Myc function.
    Katzav S; Packham G; Sutherland M; Aroca P; Santos E; Cleveland JL
    Oncogene; 1995 Sep; 11(6):1079-88. PubMed ID: 7566967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of activation of the vav protooncogene.
    Coppola J; Bryant S; Koda T; Conway D; Barbacid M
    Cell Growth Differ; 1991 Feb; 2(2):95-105. PubMed ID: 2069873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyrosine phosphorylation of Vav stimulates IL-6 production in mast cells by a Rac/c-Jun N-terminal kinase-dependent pathway.
    Song JS; Haleem-Smith H; Arudchandran R; Gomez J; Scott PM; Mill JF; Tan TH; Rivera J
    J Immunol; 1999 Jul; 163(2):802-10. PubMed ID: 10395673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav.
    Tarakhovsky A; Turner M; Schaal S; Mee PJ; Duddy LP; Rajewsky K; Tybulewicz VL
    Nature; 1995 Mar; 374(6521):467-70. PubMed ID: 7700358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyrosine kinase signalling pathways.
    Pawson T
    Princess Takamatsu Symp; 1994; 24():303-22. PubMed ID: 8983084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.